December 13, 2025 11:11 am (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
Caught in Thailand! Fugitive Goa nightclub owners detained after deadly fire kills 25 | After Putin’s blockbuster Delhi visit, Modi set to host German Chancellor Friedrich Merz in January | Delhi High Court slams govt, orders swift compensation as IndiGo crisis triggers fare shock and nationwide chaos | Amazon drops a massive $35 billion India bet! AI push, 1 million jobs and big plans revealed at Smbhav Summit | IndiGo’s ‘All OK’ claim falls apart! Govt slaps 10% flight cut after weeklong chaos | Centre finally aligns IndiGo flights with airline's operating ability, cuts its winter schedule by 5% | Odisha's Malkangiri in flames: Tribals rampage Bangladeshi settlers village after beheading horror! | Race against time! Indian Navy sends four more warships to Cyclone Ditwah-hit Sri Lanka | $2 billion mega deal! HD Hyundai to build shipyard in Tamil Nadu — a game changer for India | After 8 years of legal drama, Malayalam actor Dileep acquitted in 2017 rape case — what really happened?
Oppenheimer
Christopher Nolan's Oppenheimer opens in Japan. Photo Courtesy: X/@Oppenheimer

Christopher Nolan’s Oscar-winning ‘Oppenheimer’ finally releases in Japan, collects $2.5 million

| @indiablooms | Apr 02, 2024, at 02:10 pm

Christopher Nolan's 'Oppenheimer' minted $2.5 million from 343 theatres in Japan, the final country where the movie released nearly a year after it was released globally.

Oppenheimer emerged as one of the most successful movies of 2023 when the worldwide Box Office clash witnessed a battle between the Christopher Nolan-directed film and Barbie.

According to Universal Pictures, “Oppenheimer” is the biggest opening weekend of 2024 for a Hollywood release in Japan, surpassing “Aquaman and the Lost Kingdom” ($1.6 million) and “Dune: Part Two” ($1.3 million), reported Variety.

In Japan, it is facing challenge from local releases  “Strange House” and the animated “Haikyu!!”.

With these ticket sales, “Oppenheimer” stands at a staggering $965 million globally, Variety reported.

The success of the film in Japan was doubted ahead of the releaseof it.

It’s controversial in Japan given the subject matter of the film, which follows the American theoretical physicist J. Robert Oppenheimer (played by Cillian Murphy) who led the creation of the atomic bombs, reported Vareity.

The weapons of mass destruction were detonated in 1945 over Hiroshima and Nagasaki, killing Japanese citizens.

Oppenheimer dominates Oscars

Christopher Nolan’s Oppenheimer, the epic story of American scientist J. Robert Oppenheimer and his role in the development of the first atomic bomb, swept the Oscars night last month at the 96th Academy Awards, winning the Best Movie laurel, along with six other awards.

Nolan's blockbuster biopic on the life of Oppenheimer, who was torn between a guilt conscience and remorsefulness over the atomic bomb's catastrophic effects after the bombs were dropped in Japan at the fag end of the Second World War, won the honors for best director (Nolan), best actor (Cillian Murphy), best supporting actor (Robert Downey Jr.), best cinematography (Hoyte van Hoytema), best film editing (Jennifer Lame) and best original score (Ludwig Göransson).

Receiving the award, Murphy said, "We made a film about the man who created the atomic bomb and for better or for worse, we are all living in Oppenheimer's world, so I'd like to dedicate to the peacemakers everywhere."

Support Our Journalism

We cannot do without you.. your contribution supports unbiased journalism

IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.

Support objective journalism for a small contribution.